NextGen Biomed 2026

QEII Centre, London, UK
Follow along live as industry leaders unveil the latest advancements in biomedicine.
15:05
Panel Discussion: NextGen Vaccine Strategies To Advance Cancer Treatment
Moderator: ANTONIO POSTIGO, Chief Scientific Officer, Stratosvir Ltd
Panel Discussion: The Next Chapter Of Oligonucleotide Delivery
Moderator: STEVE HOOD, Senior Director, Oligonucleotide ADME Strategy, DMPK, GSK
Empowering Antibody Engineering – Highlights From Early Beginnings Of Using AI-Based Tools For Optimization & Functional Engineering Of Antibody Candidates
BERIT OLSEN KROGH, Senior Research Fellow, Lundbeck
Panel Discussion: Mixed Modalities: Addressing The Challenges & Opportunities To Drug The Undruggable
Multivalent Ligand Design To Selectively Bind Proteins
NATHAN ALVES, Research Director, Indiana University School Of Medicine
15:30
Cyclotides As Ultra-Stable Combinatorial Display Platforms For Peptide-Based Drug Discovery
DAVID CRAIK, Professor, University Of Queensland
Enhancing Biologics Lead Optimisation By Combining Affinity Prediction Methods & Active Learning
OWEN VICKERY, Associate Principal Scientist, AstraZeneca
InSiDe Out: In Silico Developability Screening At AstraZeneca, Impact To Date & Future Direction
ISABELLE SERMADIRAS, Associate Principal Scientist, AstraZeneca
15:55
Unveiling Hidden Targets: AI-Driven Discovery Of Therapeutic Cancer Antigens From The Dark Genome
CHRISTIAN GARDE, Director, Evaxion
The Identification Of Cyclic Peptide Metabolic Soft Spots By Isotope-Labelled Reductive Dimethylation & Leveraging High-Resolution Ion Mobility-Mass Spectrometry
MARIA FAWAZ, Associate Principal Scientist, MS
Using The Very Small To Tackle The Very Large – Our Journey From Concept To Clinic
IJEOMA UCHEGBU, Professor Of Pharmaceutical Nanoscience, University College London
First-In-Class Site-Directed Targeted soloMER Drug Conjugate For Autoimmune Inflammation
OBINNA UBAH, Principal Scientist, Elasmogen
Rationalising MABs Developability Testing
DAVID BROCKWELL, Professor, University Of Leeds
16:20
Development & Qualification Of A Cell-Based Potency Assay For Two Novel DNA Cancer Vaccine
ELISA MARELLI, Research Scientist, Scancell
Short Novel Peptides As Chelating Agents For Metal-Related Diseases
MICHAL SHOSHAN, Founder & Chief Executive Officer, metaLead Therapeutic
Purification Of Oligonucleotides & Their Conjugates For Progressing Early Drug Discovery Projects & The Chromatographic Challenges With Oligonucleotide G-rich Sequences
YIPING WU, Senior Scientist, AstraZeneca
Removing Biological Roadblocks To Better Treatments: The Power Of Nanofitin-Enhanced Biologics
MATHIEU CINIER, Scientific Director, Affilogi
From beginning to end, NextGen Biomed showcased the remarkable innovation within our community.
The event featured engaging content and discussions across the entire value chain—from antibody engineering advancements to sustainable practices in TIDES chemistry—underscoring our collective commitment to advancing immunotherapy and biologics R&D.
Explore the NextGen Biomed 2026 Programme

NextGen Biomed 2025 was supported by our
Scientific Programme Partner The Antibody Society
Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:
Panel Discussion: What Is The Next Game Changer In Antibody Engineering?
Moderator: Karen Silence, Head Preclinical Product Development, ArgenX
Panellists include Berit Olsen Krogh, Senior Research Fellow, Lundbeck; Andrew Buchanan, Principal Scientist, AstraZeneca
Presentation: What Does The Future Hold For Orally Available Peptides?
Presented by: Immanuel Lerner, Chief Executive Officer,
Pepticom
Panel Discussion: The Next Chapter Of Oligonucleotide Delivery
Moderator: Steve Hood, Senior Director, Oligonucleotide ADME Strategy, GSK
Panellists include
Saul Martinez Montero, Senior Director, RNA Therapeutics, Dyne Therapeutics
Morten Lindow, RNAHub Founder & Mission Lead, Roche
Sritama Bose, Head Of Chemistry Research & Innovation, NATA
Fazel Shabanpoor, Co-Founder & Chief Scientific Officer & Associate Professor & Head Of Pep & Oligo Therapeutics Lab, Centron Bio & The Florey Institute
Panel Discussion: Navigating The Paradigm Shift Towards Greener Approaches
Moderator: Walter Cabri, Full Professor of Organic Chemistry, University of Bologna
Panellists include Daniel Sejer Pedersen, Chemical Development Specialist CMC API Development, Novo Nordisk;
Anna Maria Papini, Full Professor & Group Leader, University of Florence;
Louis Diorazio, Senior Principal Scientist, New Modalities, AstraZeneca;
Alessandra Tolomelli, Associate Professor, University of Bologna
Presentation: How Vaccines & Immunotherapy Strategies: Converging Pathways For Preventing Or Treating Chronic Diseases
Presented by: Daniel Larocque, Innovation Lead, Innovation & Emerging Science, Sanofi
Key Event Highlights
An unmissable journey awaits you: from celebrated keynote speakers and insightful fireside chats, to an exclusive gala dinner at London's Science Museum. Discover the moments that will transform your NextGen Biomed experience.
NextGen Biomed 2026 Speakers:


















































































The 1-2-1s are the best thing about Oxford Global events, well organised and good number of relevant contacts. Good high level contacts from big companies.
Advanced Therapies Specialist Team Leader,
Genscript

Biologics 2024 has been one of the best events I have attended so far in my career.
Territorial Sales Manager UK,
ACROBiosystems Co., Ltd.

Impressed by the effort to bring people together.
Business Development Director,
Bioassay

Nice set-up, with good support for exhibitors
Director of Client Relations,
ImmunoPrecise
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Who Is Sponsoring NextGen Biomed 2026?
Gold Sponsors
Silver Sponsors

Bronze Sponsors
Network & Programme Sponsors

Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
The start-up zone provides a unique opportunity for you to exhibit, network, and pitch to our global audience of pharma, biotech, and investment professionals.
Designed for start-ups from across the biologics space, its the perfect platform to share your business plans and showcase cutting-edge therapies and innovative platform technologies.
Find out how to get started with your application, below.

Located in the heart of Westminster, the Queen Elizabeth II Centre is just minutes from three major Underground lines, Jubilee, District, and Circle via nearby Westminster and St. James’s Park stations. The venue is within walking distance of key National Rail stations including Charing Cross, Victoria, and Waterloo, and offers excellent connections to London City and Gatwick airports. Set opposite Westminster Abbey and close to Parliament Square, the QEII Centre is ideally placed for both business and leisure visitors. While there is no public parking on-site, Blue Badge holders may park on the forecourt (by prior arrangement), with public parking available nearby.
By Air
London City Airport – The QEII Centre is easily accessible from London City Airport via the DLR. Take the DLR to Bank station, then transfer to the Circle or District line to Westminster. From Westminster station, it's a short 5-minute walk to the Centre. The journey costs between £3.50 and £5, depending on time and payment method. Alternatively, a taxi will take approximately 30 minutes and cost around £40–£45, depending on traffic.
London Gatwick Airport – Take a Thameslink train from Gatwick to London Bridge (around 35 minutes), then transfer to the Jubilee line for Waterloo or Westminster. From Westminster station, it’s just a 5-minute walk to the QEII Centre. A taxi from Gatwick typically takes 60–90 minutes, with fares ranging from £65 to £85.
Heathrow Airport – From Heathrow Airport, take the Elizabeth Line to Bond Street, then transfer to the Jubilee line to Westminster Station, which is a short 5 minute walk to the QEII Centre. The Piccadilly Line to Hammersmith switching to the District Line to Westminster is also another route which can be taken. A taxi from Heathrow to the venue takes around 45 – 60 minutes and can cost from £40 - £80.
By Underground and Bus
St. James’s Park is just a four-minute walk from the Queen Elizabeth II Centre and is served by the Circle and District lines. However, please note that this station does not offer step-free access, which may be important for those with mobility needs. Alternatively, Westminster Station is approximately a five-minute walk away and provides access to the Circle, District, and Jubilee lines. Westminster is a step-free station and offers accessible routes suitable for passengers with limited mobility.
If arriving via Westminster Station, exit through Exit 6. This leads into an underground tunnel that emerges near Parliament Square. Once at street level, continue onto Whitehall, then turn left into Parliament Square. From there, cross the road and turn right onto Broad Sanctuary. The Queen Elizabeth II Centre will be on your right, directly opposite Westminster Abbey.
For those travelling by bus, routes 11, 88, and 148 all serve the area around Parliament Square. These buses will drop passengers either directly outside Westminster Abbey or within close proximity to it, offering convenient access to the venue.
By Rail
The nearest National Rail station is Charing Cross, approximately a 12-minute walk from the QEII Centre. Victoria Station is also within walking distance, taking around 14 minutes on foot, while Waterloo Station is slightly further, at about an 18-minute walk. All three stations offer excellent transport links across London and beyond.
By Car
Leave the A4 at the Lancaster Place/Aldwych exit and continue onto the Strand. At Trafalgar Square, take the third exit onto Northumberland Avenue. Follow it to Victoria Embankment, then turn right. Continue briefly, then turn left onto Bridge Street. At Parliament Square, bear left onto Broad Sanctuary. The Queen Elizabeth II Centre will be on your right, opposite Westminster Abbey. Nearby public parking is available.
Parking
The QEII Centre does not offer public car parking facilities. However, Blue Badge holders are permitted to park on the Centre’s forecourt free of charge, subject to availability. Visitors are advised to call ahead on +44 20 7798 4000 to confirm access. Disabled passengers arriving by taxi or other vehicles may also be dropped off on the forecourt. For other visitors, JustPark offers nearby parking spaces, with prices starting from £3.30. Please see here.
More information on Accommodation will be coming soon.
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2026, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of NextGen Biomed 2026 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.
Partner with us
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients